全文获取类型
收费全文 | 2866740篇 |
免费 | 379407篇 |
国内免费 | 41637篇 |
专业分类
耳鼻咽喉 | 38104篇 |
儿科学 | 92596篇 |
妇产科学 | 74665篇 |
基础医学 | 430839篇 |
口腔科学 | 76908篇 |
临床医学 | 281107篇 |
内科学 | 584042篇 |
皮肤病学 | 62634篇 |
神经病学 | 223824篇 |
特种医学 | 110521篇 |
外国民族医学 | 868篇 |
外科学 | 437738篇 |
综合类 | 107090篇 |
现状与发展 | 5篇 |
一般理论 | 862篇 |
预防医学 | 230199篇 |
眼科学 | 78222篇 |
药学 | 245062篇 |
11篇 | |
中国医学 | 52871篇 |
肿瘤学 | 159616篇 |
出版年
2019年 | 33745篇 |
2018年 | 43354篇 |
2017年 | 36712篇 |
2016年 | 37680篇 |
2015年 | 40802篇 |
2014年 | 51531篇 |
2013年 | 70305篇 |
2012年 | 91850篇 |
2011年 | 97712篇 |
2010年 | 65515篇 |
2009年 | 67840篇 |
2008年 | 89774篇 |
2007年 | 91831篇 |
2006年 | 91836篇 |
2005年 | 88378篇 |
2004年 | 87994篇 |
2003年 | 83900篇 |
2002年 | 81435篇 |
2001年 | 143163篇 |
2000年 | 143426篇 |
1999年 | 124646篇 |
1998年 | 40317篇 |
1997年 | 35698篇 |
1996年 | 35751篇 |
1995年 | 34786篇 |
1994年 | 32734篇 |
1993年 | 30138篇 |
1992年 | 96535篇 |
1991年 | 93798篇 |
1990年 | 90216篇 |
1989年 | 86773篇 |
1988年 | 79950篇 |
1987年 | 78007篇 |
1986年 | 73223篇 |
1985年 | 69328篇 |
1984年 | 51722篇 |
1983年 | 44392篇 |
1982年 | 27662篇 |
1981年 | 25015篇 |
1979年 | 46568篇 |
1978年 | 33083篇 |
1977年 | 28936篇 |
1976年 | 26825篇 |
1975年 | 28387篇 |
1974年 | 33458篇 |
1973年 | 31862篇 |
1972年 | 29909篇 |
1971年 | 27127篇 |
1970年 | 25503篇 |
1969年 | 23390篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
目的 通过分析特发性肺纤维化急性加重期(AE-IPF)患者证候与血清生物标志物的关系,为中医辨证治疗提供参考。方法 采用观察性研究设计,收集2019年3月至2019年11月三个中心的AE-IPF患者76例,其中痰热壅肺证26例、痰浊阻肺证50例,并纳入健康志愿者10例作为对照。采用ELISA测定患者血清CCL18、HMGB1、KL-6、MMP-7、SP-A和SP-D水平,分析与中医证候的相关性。结果 AE-IPF患者血清CCL18、HMGB1、KL-6、MMP-7、SP-A和SP-D水平均显著高于健康对照组。血清CCL18、HMGB1、KL-6、MMP-7和SP-D水平在痰热壅肺证和痰浊阻肺证患者间无显著性差异(P>0.05),而血清SP-A水平存在显著性差异(P<0.05)。结论 血清SP-A与AE-IPF证候存在一定的相关性,血清SP-A的浓度升高,与痰热壅肺证关系越密切,反之,血清SP-A浓度降低,则与痰浊阻肺证关系越密切。AE-IPF痰热壅肺证患者的预后可能较痰浊阻肺证患者更差。 相似文献
33.
Purnima Gogoi Geetika Kaur Nikhlesh K Singh 《World journal of gastroenterology : WJG》2022,28(46):6497-6511
Colorectal cancer (CRC) is the third most diagnosed cancer and the second leading cause of cancer-related mortality in the United States. Across the globe, people in the age group older than 50 are at a higher risk of CRC. Genetic and environmental risk factors play a significant role in the development of CRC. If detected early, CRC is preventable and treatable. Currently, available screening methods and therapies for CRC treatment reduce the incidence rate among the population, but the micrometastasis of cancer may lead to recurrence. Therefore, the challenge is to develop an alternative therapy to overcome this complication. Nanotechnology plays a vital role in cancer treatment and offers targeted chemotherapies directly and selectively to cancer cells, with enhanced therapeutic efficacy. Additionally, nanotechnology elevates the chances of patient survival in comparison to traditional chemotherapies. The potential of nanoparticles includes that they may be used simultaneously for diagnosis and treatment. These exciting properties of nanoparticles have enticed researchers worldwide to unveil their use in early CRC detection and as effective treatment. This review discusses contemporary methods of CRC screening and therapies for CRC treatment, while the primary focus is on the theranostic approach of nanotechnology in CRC treatment and its prospects. In addition, this review aims to provide knowledge on the advancement of nanotechnology in CRC and as a starting point for researchers to think about new therapeutic approaches using nanotechnology. 相似文献
34.
35.
36.
M.-A. Fauroux A. Germa P. Tramini C. Nabet 《Revue d'épidémiologie et de santé publique》2019,67(4):223-231
BackgroundThe aim of this study was to estimate the prevalence of dental prosthetic treatment and to investigate the demographic, social, economic and medical factors associated with the use of fixed and removable dentures in a representative sample of adults living in France.MethodsThe data were obtained from the 2002–2003 Decennial Health Survey, a cross-sectional study of a representative sample of the population living in France, which included 29,679 adults. Information was collected by interview. The variables collected were fixed denture, removable denture, age, gender, number of children, area of residence, nationality, educational attainment, family social status, employment status, annual household income per capita, supplementary insurance, chronic disease, eyesight problems/glasses, hearing problems/hearing aids. Multinomial logistic regression models were used to study the relationship between prosthetic treatment and demographic, socioeconomic and medical characteristics unadjusted, adjusted for age and adjusted for all the characteristics.ResultsThe prevalence of prosthetic treatment was 34.6% (95% confidence interval (CI): [34.1; 35.2]) for fixed prosthetic dentures and 13.8% (95% CI: [13.4; 14.2]) for removable prosthetic dentures. We showed a gradient between educational attainment and removable dentures; the odds ratio adjusted for all the variables (aOR) associated with no or primary education compared to post-secondary education was 2.56; 95% CI: [2.09; 3.13]. When annual household income per capita was low, subjects were less likely to report fixed dentures (aOR = 0.68; 95% CI: [0.62; 0.75]) than those with high annual household income per capita. Individuals without insurance less often reported fixed dentures than those with private insurance. Those reporting chronic disease were less likely to report fixed dentures (aOR = 0.87; 95% CI: [0.79; 0.95]) but more likely to report removable dentures (aOR = 1.29; 95% CI: [1.17; 1.43]) than those without chronic disease.ConclusionThis study reveals social, economic and medical inequalities in fixed and removable prosthetic treatment among adults in France. 相似文献
37.
38.
39.
40.
【摘要】目的 观察川陈皮素对糖尿病肾病大鼠的治疗作用,并从腺苷酸蛋白活化激酶(AMPK)和内皮型一氧化氮酶(eNOS)途径探讨其作用机理。方法 采用高脂高糖饲料喂养+链脲佐菌素(STZ)腹腔注射复制2型糖尿病肾脏损害大鼠模型,模型构建成功后,将其随机分为正常组、模型组、贝那普利干预组以及川陈皮素低、中和高剂量治疗组(n=20)。实验中密切监测大鼠一般情况,治疗期结束后收集尿液检测24h蛋白尿,收集血液检测肾功能指标、抗氧化指标,收集肾脏观察肾脏病理学,同时检测肾脏组织中AMPK及eNOS蛋白和mRNA的表达结果。结果 正常组肾小球正常,无明显病理特征;模型组出现肾小球增大,系膜和肾间质纤维组织增生;贝那普利组和川陈皮素三个剂量组相较于模型组明显减轻。与正常组相比,模型组24h尿蛋白定量、UREA、CREA和MDA明显升高(P<005);SOD和GSH明显降低(P<005),与模型组相比,贝那普利和川陈皮素三个剂量组24h尿蛋白定量、UREA、CREA和MDA明显降低(P<005),SOD和GSH明显升高(P<005)。与正常组相比,模型组p AMPK、AMPK和eNOS蛋白和mRNA表达均明显降低(P<005);与模型组相比,贝那普利组和川陈皮素低、中和高剂量组AMPK和eNOS蛋白和mRNA表达明显升高(P<005)。结论 川陈皮素可保护肾功能,提高血清和肾脏抗氧化指标,同时增加AMPK和eNOS蛋白和mRNA表达,最终保护糖尿病肾脏损害。 相似文献